Back
Delta Air Lines, Inc. Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison
Buy
70
DAL
Delta Air Lines, Inc.
Last Price:
$70.95
Seasonality Move:
-3.63%
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.33
Seasonality Move:
6.08%
Buy
70
Delta Air Lines, Inc. (DAL)
is a Buy
Is Delta Air Lines, Inc. a Buy, Sell or Hold?
-
The current Delta Air Lines, Inc. [DAL] share price is $70.96. The Score for DAL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
DAL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.32. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAL Stock Price Chart
What is Delta Air Lines, Inc.'s stock price today?
-
The Delta Air Lines, Inc. share price today is $70.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAL is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.68 | Buy |
| Relative Strength Index (14 RSI): | 64.92 | Buy |
| Chaikin Money Flow: | 900888 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.99 - 71.25) | Buy |
| Bollinger Bands (100): | (56.26 - 65.28) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.69 | Buy |
| Relative Strength Index (14 RSI): | 57.4 | Buy |
| Chaikin Money Flow: | 705480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.05 - 22.53) | Buy |
| Bollinger Bands (100): | (17.77 - 22.29) | Buy |
DAL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.86 | Buy |
| 20-day SMA: | 68.56 | Buy |
| 50-day SMA: | 62.8 | Buy |
| 200-day SMA: | 54.34 | Buy |
| 8-day EMA: | 70.54 | Buy |
| 20-day EMA: | 68.24 | Buy |
| 50-day EMA: | 63.53 | Buy |
| 200-day EMA: | 39.92 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.49 | Buy |
| 20-day SMA: | 21.54 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.87 | Sell |
| 8-day EMA: | 16.81 | Buy |
| 20-day EMA: | 9.68 | Buy |
| 50-day EMA: | 4.56 | Buy |
| 200-day EMA: | 1.24 | Buy |
Delta Air Lines, Inc. Earnings Growth & DAL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $1.31 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
Delta Air Lines, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||